214 related articles for article (PubMed ID: 11739795)
21. Activation of cyclin A gene expression by the cyclin encoded by human herpesvirus-8.
Duro D; Schulze A; Vogt B; Bartek J; Mittnacht S; Jansen-D ºrr P
J Gen Virol; 1999 Mar; 80 ( Pt 3)():549-555. PubMed ID: 10091992
[TBL] [Abstract][Full Text] [Related]
22. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation.
Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H
Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase).
Tassan JP; Schultz SJ; Bartek J; Nigg EA
J Cell Biol; 1994 Oct; 127(2):467-78. PubMed ID: 7929589
[TBL] [Abstract][Full Text] [Related]
24. Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication.
Laman H; Coverley D; Krude T; Laskey R; Jones N
Mol Cell Biol; 2001 Jan; 21(2):624-35. PubMed ID: 11134348
[TBL] [Abstract][Full Text] [Related]
25. Structural basis for CDK6 activation by a virus-encoded cyclin.
Schulze-Gahmen U; Kim SH
Nat Struct Biol; 2002 Mar; 9(3):177-81. PubMed ID: 11828325
[TBL] [Abstract][Full Text] [Related]
26. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
Upton JW; van Dyk LF; Speck SH
Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
[TBL] [Abstract][Full Text] [Related]
27. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner.
Ko LJ; Shieh SY; Chen X; Jayaraman L; Tamai K; Taya Y; Prives C; Pan ZQ
Mol Cell Biol; 1997 Dec; 17(12):7220-9. PubMed ID: 9372954
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.
Connell-Crowley L; Solomon MJ; Wei N; Harper JW
Mol Biol Cell; 1993 Jan; 4(1):79-92. PubMed ID: 8443411
[TBL] [Abstract][Full Text] [Related]
29. Fission yeast Csk1 is a CAK-activating kinase (CAKAK).
Hermand D; Pihlak A; Westerling T; Damagnez V; Vandenhaute J; Cottarel G; Mäkelä TP
EMBO J; 1998 Dec; 17(24):7230-8. PubMed ID: 9857180
[TBL] [Abstract][Full Text] [Related]
30. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
Easton J; Wei T; Lahti JM; Kidd VJ
Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
[TBL] [Abstract][Full Text] [Related]
31. A cyclin-dependent kinase-activating kinase (CAK) in budding yeast unrelated to vertebrate CAK.
Espinoza FH; Farrell A; Erdjument-Bromage H; Tempst P; Morgan DO
Science; 1996 Sep; 273(5282):1714-7. PubMed ID: 8781234
[TBL] [Abstract][Full Text] [Related]
32. KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo.
Pekkonen P; Järviluoma A; Zinovkina N; Cvrljevic A; Prakash S; Westermarck J; Evan GI; Cesarman E; Verschuren EW; Ojala PM
Cell Cycle; 2014; 13(23):3670-84. PubMed ID: 25483078
[TBL] [Abstract][Full Text] [Related]
33. Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity.
Martinez AM; Afshar M; Martin F; Cavadore JC; Labbé JC; Dorée M
EMBO J; 1997 Jan; 16(2):343-54. PubMed ID: 9029154
[TBL] [Abstract][Full Text] [Related]
34. Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2.
Desai D; Wessling HC; Fisher RP; Morgan DO
Mol Cell Biol; 1995 Jan; 15(1):345-50. PubMed ID: 7799941
[TBL] [Abstract][Full Text] [Related]
35. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors.
Fink JR; LeBien TW
Exp Hematol; 2001 Apr; 29(4):490-8. PubMed ID: 11301189
[TBL] [Abstract][Full Text] [Related]
36. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
[TBL] [Abstract][Full Text] [Related]
37. Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK).
Mandal M; Bandyopadhyay D; Goepfert TM; Kumar R
Oncogene; 1998 Jan; 16(2):217-25. PubMed ID: 9464540
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.
Russo AA; Tong L; Lee JO; Jeffrey PD; Pavletich NP
Nature; 1998 Sep; 395(6699):237-43. PubMed ID: 9751050
[TBL] [Abstract][Full Text] [Related]
39. Analysis of CAK activities from human cells.
Kaldis P; Solomon MJ
Eur J Biochem; 2000 Jul; 267(13):4213-21. PubMed ID: 10866826
[TBL] [Abstract][Full Text] [Related]
40. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
Morisaki H; Ando A; Nagata Y; Pereira-Smith O; Smith JR; Ikeda K; Nakanishi M
Exp Cell Res; 1999 Dec; 253(2):503-10. PubMed ID: 10585273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
